文献速递系统性红斑狼疮

系统性红斑狼疮中的恶病质:危险因素及其与疾病活动度和损伤的关系

Cachexia in Systemic Lupus Erythematosus: Risk Factors and Relation to Disease Activity and Damage.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-10-07

该研究基于2452例前瞻性SLE队列,采用改良Fearon标准定义恶病质,发现5年内56%患者发生恶病质,其中18%随访期间体重未恢复。危险因素包括BMI<20 kg/m²、当前使用激素、血管炎、狼疮肾炎、浆膜炎、血液系统表现及抗dsDNA、抗Sm、抗RNP阳性。间歇性恶病质患者SDI评分显著更高。

要点

  • SLE患者5年内恶病质发生率高达56%,18%体重未恢复。
  • BMI<20 kg/m²、当前激素使用及多系统受累是恶病质危险因素。
  • 间歇性恶病质患者未来器官损伤风险最高。

核心结论

  • 恶病质是SLE中未被充分认识的综合征,间歇性恶病质患者未来器官损伤风险最高。

研究设计与样本

  • 前瞻性SLE队列研究,共2452例患者每次访视评估体重,按体重分为5组,采用改良Fearon标准定义恶病质,用Kaplan-Meier估计5年风险,Cox回归分析危险因素,方差分析比较SDI评分。

主要发现

  • 队列入组后5年内56%患者发生恶病质,其中18%随访期间体重未恢复。
  • 恶病质危险因素包括BMI<20 kg/m²、当前使用激素、血管炎、狼疮肾炎、浆膜炎、血液系统狼疮表现、抗dsDNA阳性、抗Sm阳性及抗RNP阳性。
  • 间歇性恶病质患者SDI评分显著高于持续性恶病质或无恶病质患者。

关键数值与推荐

  • 恶病质定义采用改良Fearon标准:6个月内非饥饿状态下稳定体重下降5%相对于既往所有访视平均体重,和/或非饥饿状态下体重下降>2%相对于既往所有队列访视平均体重且BMI<20 kg/m²。

临床怎么用

  • 对SLE患者应监测体重变化,尤其关注BMI<20 kg/m²、当前使用激素及有血管炎、肾炎、浆膜炎、血液系统受累或自身抗体阳性者。
  • 间歇性恶病质患者需警惕未来器官损伤,应加强随访和干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cachexia is a disorder characterized by involuntary weight loss in addition to loss of homeostatic control of both energy and protein balance. Despite an abundance of data from other inflammatory diseases, cachexia in systemic lupus erythematosus (SLE) remains a largely undescribed syndrome. The present study was undertaken to define the prevalence of cachexia in SLE and to identify the main factors that place patients at risk of developing cachexia. METHODS: A total of 2,452 patients in a prospective SLE cohort had their weight assessed at each visit. Patients were categorized into 5 predetermined groups based on weight. Cachexia was defined based on modified Fearon criteria (5% stable weight loss in 6 months without starvation relative to the average weight in all prior visits and/or a weight loss of >2% without starvation relative to the average weight in all prior cohort visits and a body mass index [BMI] of <20 kg/m2 ). Risk of cachexia within 5 years of cohort entry was based on Kaplan-Meier estimates. The association of prior disease manifestations with risk of cachexia adjusted by current steroid use was determined using Cox regression. An analysis of variance test was used to determine whether Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) scores varied based on cachexia status. RESULTS: Within 5 years of cohort entry, 56% of patients developed cachexia, 18% of which never recovered their weight during follow-up. The risk factors for cachexia development were a BMI of <20 kg/m2 , current steroid use, vasculitis, lupus nephritis, serositis, hematologic lupus manifestations, positive anti-double-stranded DNA, anti-Sm, and anti-RNP. Patients with intermittent cachexia had significantly higher SDI scores compared to those with continuous cachexia or without cachexia. CONCLUSION: Cachexia is an underrecognized syndrome in patients with SLE. SLE patients with intermittent cachexia have the highest risk of future organ damage.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Stojan G, Li J, Wittmaack A, et al. Cachexia in Systemic Lupus Erythematosus: Risk Factors and Relation to Disease Activity and Damage. Arthritis Care Res (Hoboken). 2021. PMID: 32741060. doi:10.1002/acr.24395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。